| Literature DB >> 26320657 |
Xinyang Song1, Dai Dai1, Xiao He2, Shu Zhu1, Yikun Yao1, Hanchao Gao1, Jingjing Wang1, Fangfang Qu1, Ju Qiu1, Honglin Wang3, Xiaoxia Li4, Nan Shen5, Youcun Qian6.
Abstract
The intestinal epithelial barrier plays a critical role in the mucosal immunity. However, it remains largely unknown how the epithelial barrier is maintained after damage. Here we show that growth factor FGF2 synergized with interleukin-17 (IL-17) to induce genes for repairing of damaged epithelium. FGF2 or IL-17 deficiency resulted in impaired epithelial proliferation, increased pro-inflammatory microbiota outgrowth, and consequently worse pathology in a DSS-induced colitis model. The dysregulated microbiota in the model induced transforming growth factor beta 1 (TGFβ1) expression, which in turn induced FGF2 expression mainly in regulatory T cells. Act1, an essential adaptor in IL-17 signaling, suppressed FGF2-induced ERK activation through binding to adaptor molecule GRB2 to interfere with its association with guanine nucleotide exchange factor SOS1. Act1 preferentially bound to IL-17 receptor complex, releasing its suppressive effect on FGF2 signaling. Thus, microbiota-driven FGF2 and IL-17 cooperate to repair the damaged intestinal epithelium through Act1-mediated direct signaling cross-talk.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26320657 DOI: 10.1016/j.immuni.2015.06.024
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745